Corporate Headquarters

 

Injectsense, Inc.
2000 Powell St

Suite 1425 
Emeryville, CA 94608

 

(510) 292-4120
 

 

 

Twin Cities

 

Injectsense, Inc.

7825 Washington Ave. South

Suite 650

Minneapolis, MN 55439

 

 

 

 

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Facebook Social Icon

Investor Information

 

Injectsense received Series B funding in April 2019 for development and testing of its sensor enabled digital health system. It is currently engaged in raising funds for Series C. The company also generates revenue from projects with healthcare strategics and solution partners. 

 

To learn more about the company and investment opportunities, please contact

                                 .

CAUTION - Investigational Device. Limited by Federal law to investigational use.